Insomnia and Delayed Sleep Onset: Medical Causes, Neurobiology, and Evidence-Based Treatments for Nighttime Wakefulness

Insomnia and delayed sleep onset refer to difficulty initiating sleep, maintaining sleep, or achieving restorative sleep despite adequate opportunity. In practice, many people describe this as being “still yet to sleep,” a pattern commonly driven by circadian misalignment, hyperarousal of the nervous system, behavioral sleep conditioning, and comorbid medical or psychiatric conditions. Clinically, insomnia is characterized by dissatisfaction with sleep quantity or quality, with daytime impairment such as fatigue, cognitive slowing, mood disturbance, or reduced functional performance.

Neurobiologically, sleep initiation is regulated by a coordinated interaction between circadian timing systems and sleep-wake homeostasis. The circadian system is centered in the suprachiasmatic nucleus (SCN) of the hypothalamus, which synchronizes to light-dark cues. When light exposure occurs late in the evening or chronically irregular schedules shift circadian phase, melatonin timing is delayed and the physiologic signal for nighttime sleepiness is postponed. Sleep homeostasis, governed in part by adenosinergic signaling, increases pressure for sleep throughout wakefulness; however, hyperarousal states can counteract this pressure by maintaining elevated cortical and sympathetic activation.

A major mechanism behind insomnia is conditioned arousal: repeated pairing of bed with wakefulness trains the brain to treat the bedroom as a place of alertness rather than sleep. Cognitive arousal also matters. Rumination about performance, health, or next-day obligations can activate cognitive control networks and stress physiology, amplifying sympathetic outflow and weakening the transition to N1 sleep stages. Behavioral components such as irregular bedtime, prolonged time in bed, napping late in the day, and inconsistent wake times sustain insomnia by fragmenting both homeostatic and circadian processes.

Delayed sleep onset is especially common in circadian rhythm sleep-wake disorders. Even when total sleep time is sufficient, an individual’s preferred biological phase may be shifted later, causing sleep to occur well after midnight when social or work demands require early morning awakening. This leads to chronic sleep restriction, which then worsens mood and attention. Substance-related factors also play a role: caffeine—particularly if taken in the afternoon or evening—blocks adenosine receptors; nicotine and alcohol can destabilize sleep architecture and promote awakenings later in the night. Certain medications (e.g., stimulants, some antidepressants, corticosteroids) may further delay sleep.

Comorbid conditions frequently coexist with insomnia. Anxiety disorders can produce persistent worry and increased physiologic arousal, while depressive disorders often alter sleep timing and cause early morning awakening, though delayed onset can occur in atypical or stress-related presentations. Pain syndromes, gastroesophageal reflux, asthma, restless legs syndrome, and obstructive sleep apnea can fragment sleep and perpetuate insomnia by maintaining nocturnal awakenings. Therefore, evaluation should include screening for secondary causes before labeling primary insomnia.

Assessment commonly uses a sleep history, sleep diary, and sometimes validated questionnaires such as the Insomnia Severity Index. Clinicians may ask about sleep timing, latency (time to fall asleep), awakenings, total sleep time, daytime impairment, naps, caffeine and alcohol use, medications, and behaviors in bed. If symptoms suggest sleep-disordered breathing or periodic limb movements, polysomnography or home sleep apnea testing may be indicated.

Evidence-based treatment begins with cognitive behavioral therapy for insomnia (CBT-I), which is considered first-line. CBT-I includes stimulus control (using the bed only for sleep and intimacy; leaving the bed if unable to sleep), sleep restriction therapy (temporarily limiting time in bed to consolidate sleep, then gradually increasing it), cognitive restructuring (reducing maladaptive beliefs about sleep), and sleep hygiene strategies (consistent wake time, reducing evening light exposure, limiting caffeine). A key physiologic aim is to recalibrate arousal and restore circadian alignment while strengthening homeostatic sleep pressure.

Pharmacotherapy is sometimes used short-term or when CBT-I access is limited. Sedative-hypnotics can reduce sleep latency but carry risks such as next-day impairment, tolerance, dependence, and in some populations increased risk of falls or complex sleep behaviors. Melatonin or melatonin receptor agonists may be helpful in circadian phase delay, particularly when treatment targets biological timing rather than insomnia alone. Choice of medication should consider comorbidities, risk factors, and duration.

Practical risk-reduction strategies include establishing a fixed wake time, minimizing bright light and screens close to bedtime, engaging in daytime outdoor light to advance circadian phase when appropriate, and creating a consistent pre-sleep routine. For delayed sleep onset, earlier morning light and timed melatonin (when appropriate and guided by a clinician) may help shift circadian timing. Patients should also address contributing conditions such as restless legs, reflux, pain, and anxiety to break the insomnia perpetuation cycle.

When insomnia is persistent (e.g., at least three nights per week for three months) or accompanied by significant daytime impairment, urgent evaluation may be warranted, especially if red flags are present such as severe snoring with witnessed apneas, leg discomfort with an urge to move at night, or suicidal ideation in severe depression. In most cases, structured CBT-I combined with targeted management of secondary causes can produce durable improvements.

Source: @Tony_Aladetuyi